Abstract
Although gene polymorphisms in the renin-angiotensin system (RAS) are predisposing factors for cardiovascular diseases, the precise mechanisms and interactions among confounding factors have not been clarified. We investigated whether genetic variants of RAS are involved in insulin sensitivity in a Japanese general population. During a medical checkup in 2001, participants (n=550) were recruited from among the residents of the towns of Tanno and Sobetsu, and written informed consent was obtained to participate in the genetic analysis and the epidemiological study. The insertion/deletion (I/D) polymorphism of the angiotensin-converting enzyme gene (ACE), the Met235Thr polymorphism of the angiotensinogen gene (AGT), and the A1166C polymorphism of the angiotensin II type 1 receptor gene (AGTR1) were determined by gel electrophoresis or the TaqMan PCR method. We assessed insulin sensitivity using the homeostasis model assessment insulin resistance (HOMA-IR). The RAS gene polymorphisms were not associated with log-transformed values of HOMA-IR, whereas borderline association (p=0.02) was found between the A1166C polymorphism and dichotomous categorization of insulin resistance (defined as HOMA-IR ≥1.73). Our results suggested that the A1166C polymorphism of AGTR1 might affect insulin resistance by altering the responsiveness to angiotensin II signaling, though this mechanism is as yet inconclusive. Further study is required to confirm these findings in a larger, multi-ethnic population.
Similar content being viewed by others
Article PDF
References
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–2497.
Ford ES, Giles WH, Dietz WH : Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356–359.
Takeuchi H, Saitoh S, Takagi S, et al: Metabolic syndrome and insulin resistance in Japanese males—Tanno-Sobetsu study. J Jpn Diabet Soc 2003; 46: 739–744.
Lakka HM, Laaksonen DE, Lakka TA, et al: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709–2716.
Isomaa B, Almgren P, Tuomi T, et al: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683–689.
Takeuchi H, Saitoh S, Takagi S, et al: Metabolic syndrome and cardiac disease in Japanese men: applicability of the concept of metabolic syndrome defined by the National Cholesterol Education Program–Adult Treatment Panel III to Japanese men—the Tanno and Sobetsu study. Hypertens Res 2005; 28: 203–208.
Cheal KL, Abbasi F, Lamendola C, McLaughlin T, Reaven GM, Ford ES : Relationship to insulin resistance of the adult treatment panel III diagnostic criteria for identification of the metabolic syndrome. Diabetes 2004; 53: 1195–1200.
Reaven GM : Pathophysiology of insulin resistance in human disease. Physiol Rev 1995; 75: 473–486.
Higashiura K, Ura N, Takada T, et al: The effects of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonist on insulin resistance in fructose-fed rats. Am J Hypertens 2000; 13: 290–297.
Ura N, Higashiura K, Shimamoto K : The mechanisms of insulin sensitivity improving effects of angiotensin converting enzyme inhibitor. Immunopharmacology 1999; 44: 153–159.
Peach MJ : Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev 1977; 57: 313–370.
Katsuya T, Horiuchi M, Chen YD, et al: Relations between deletion polymorphism of the angiotensin-converting enzyme gene and insulin resistance, glucose intolerance, hyperinsulinemia, and dyslipidemia. Arterioscler Thromb Vasc Biol 1995; 15: 779–782.
Perticone F, Ceravolo R, Iacopino S, et al: Relationship between angiotensin-converting enzyme gene polymorphism and insulin resistance in never-treated hypertensive patients. J Clin Endocrinol Metab 2001; 86: 172–178.
Yamamoto J, Kageyama S, Sakurai T, et al: Insulin resistance and angiotensin converting enzyme polymorphism in Japanese hypertensive subjects. Hypertens Res 1999; 22: 81–84.
Ohira N, Matsumoto T, Tamaki S, et al: Angiotensin-converting enzyme insertion/deletion polymorphism modulates coronary release of tissue plasminogen activator in response to bradykinin. Hypertens Res 2004; 27: 39–45.
Saeed M, Saleheen D, Siddiqui S, Khan A, Butt ZA, Frossard PM : Association of angiotensin converting enzyme gene polymorphisms with left ventricular hypertrophy. Hypertens Res 2005; 28: 345–349.
Sugimoto K, Katsuya T, Ohkubo T, et al: Association between angiotensin II type 1 receptor gene polymorphism and essential hypertension: the Ohasama Study. Hypertens Res 2004; 27: 551–556.
Jin JJ, Nakura J, Wu Z, et al: Association of angiotensin II type 2 receptor gene variant with hypertension. Hypertens Res 2003; 26: 547–552.
Kikuya M, Sugimoto K, Katsuya T, et al: A/C1166 gene polymorphism of the angiotensin II type 1 receptor (AT1) and ambulatory blood pressure: the Ohasama Study. Hypertens Res 2003; 26: 141–145.
Ono K, Mannami T, Baba S, Yasui N, Ogihara T, Iwai N : Lack of association between angiotensin II type 1 receptor gene polymorphism and hypertension in Japanese. Hypertens Res 2003; 26: 131–134.
Tiret L, Bonnardeaux A, Poirier O, et al: Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet 1994; 344: 910–913.
Fujiwara T, Saitoh S, Takagi S, et al: Prevalence of asymptomatic arteriosclerosis obliterans and its relationship with risk factors in inhabitants of rural communities in Japan: Tanno-Sobetsu study. Atherosclerosis 2004; 177: 83–88.
Ohnishi H, Saitoh S, Takagi S, et al: Pulse wave velocity as an indicator of atherosclerosis in impaired fasting glucose: the Tanno and Sobetsu study. Diabetes Care 2003; 26: 437–440.
Ohnishi H, Saitoh S, Ura N, et al: Relationship between insulin resistance and accumulation of coronary risk factors. Diabetes Obes Metab 2002; 4: 388–393.
Oimatsu H, Saitoh S, Ura N, Shimamoto K : A practical index for evaluation of insulin resistance. J Jpn Diabet Soc 2000; 43: 205–213.
Katsuya T, Ishikawa K, Sugimoto K, Rakugi H, Ogihara T : Salt sensitivity of Japanese from the viewpoint of gene polymorphism. Hypertens Res 2003; 26: 521–525.
Higaki J, Baba S, Katsuya T, et al: Deletion allele of angiotensin-converting enzyme gene increases risk of essential hypertension in Japanese men: the Suita Study. Circulation 2000; 101: 2060–2065.
Katsuya T, Koike G, Yee TW, et al: Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet 1995; 345: 1600–1603.
Fujisawa T, Ikegami H, Yamato E, et al: Association of Trp64Arg mutation of the beta3-adrenergic-receptor with NIDDM and body weight gain. Diabetologia 1996; 39: 349–352.
D'Adamo M, Perego L, Cardellini M, et al: The −866A/A genotype in the promoter of the human uncoupling protein 2 gene is associated with insulin resistance and increased risk of type 2 diabetes. Diabetes 2004; 53: 1905–1910.
Murase Y, Yagi K, Katsuda Y, Asano A, Koizumi J, Mabuchi H : An LMNA variant is associated with dyslipidemia and insulin resistance in the Japanese. Metabolism 2002; 51: 1017–1021.
Kondo H, Shimomura I, Matsukawa Y, et al: Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome. Diabetes 2002; 51: 2325–2328.
Buzzetti R, Petrone A, Ribaudo MC, et al: The common PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivity. Eur J Hum Genet 2004; 12: 1050–1054.
Gillespie EL, White CM, Kardas M, Lindberg M, Coleman CI : The impact of ACE inhibitors or angiotensin II type 1 receptor blockers on the development of new-onset type 2 diabetes. Diabetes Care 2005; 28: 2261–2266.
Shinozaki K, Ayajiki K, Nishio Y, Sugaya T, Kashiwagi A, Okamura T : Evidence for a causal role of the renin-angiotensin system in vascular dysfunction associated with insulin resistance. Hypertension 2004; 43: 255–262.
Tan M, Xu X, Ohba M, Cui MZ : Angiotensin II–induced protein kinase D activation is regulated by protein kinase Cdelta and mediated via the angiotensin II type 1 receptor in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2004; 24: 2271–2276.
Suzuki H, Motley ED, Frank GD, Utsunomiya H, Eguchi S : Recent progress in signal transduction research of the angiotensin II type-1 receptor: protein kinases, vascular dysfunction and structural requirement. Curr Med Chem Cardiovasc Hematol Agents 2005; 3: 305–322.
van Geel PP, Pinto YM, Buikema H, van Gilst WH : Is the A1166C polymorphism of the angiotensin II type 1 receptor involved in cardiovascular disease? Eur Heart J 1998; 19 ( Suppl G): G13–G17.
Miller JA, Thai K, Scholey JW : Angiotensin II type 1 receptor gene polymorphism predicts response to losartan and angiotensin II. Kidney Int 1999; 56: 2173–2180.
Umeda M, Kanda T, Murakami M : Effects of angiotensin II receptor antagonists on insulin resistance syndrome and leptin in sucrose-fed spontaneously hypertensive rats. Hypertens Res 2003; 26: 485–492.
Shiuchi T, Iwai M, Li HS, et al: Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice. Hypertension 2004; 43: 1003–1010.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Akasaka, H., Katsuya, T., Saitoh, S. et al. Effects of Angiotensin II Type 1 Receptor Gene Polymorphisms on Insulin Resistance in a Japanese General Population: The Tanno-Sobetsu Study. Hypertens Res 29, 961–967 (2006). https://doi.org/10.1291/hypres.29.961
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1291/hypres.29.961
Keywords
This article is cited by
-
Influence of Renin Angiotensin System Gene Polymorphisms on Visit-to-Visit Blood Pressure Variability in Hypertensive Patients
American Journal of Hypertension (2012)
-
Possible role of microsomal epoxide hydrolase gene polymorphism as a risk factor for developing insulin resistance and type 2 diabetes mellitus
Endocrine (2012)
-
Angiotensin-converting enzyme single nucleotide polymorphism is a genetic risk factor for cardiovascular disease: a cohort study of hypertensive patients
Hypertension Research (2011)
-
Variation in OSBPL10 is associated with dyslipidemia
Hypertension Research (2010)
-
Association of gene polymorphism of the fat-mass and obesity-associated gene with insulin resistance in Japanese
Hypertension Research (2010)